Patent Landscape and Claims Analysis for U.S. Patent 9,861,584
What is the scope of U.S. Patent 9,861,584?
U.S. Patent 9,861,584 covers a specific formulation and use of a method for treating a disease with a novel compound. Its claims primarily protect the chemical composition, manufacturing process, and therapeutic application of a new drug candidate. The scope encompasses:
- Composition of matter: The patent claims a specific chemical compound or a class of compounds.
- Method of use: It delineates therapeutic methods, such as administering the compound for treatment of particular indications (e.g., cancer, autoimmune disease).
- Manufacturing process: It describes a process for synthesis or formulation.
The patent’s claims are structured to prevent others from creating, using, or selling the compound or similar formulations for the scoped indications without licensing.
What are the key claims of U.S. Patent 9,861,584?
The patent’s independent claims focus on:
- Claim 1: A chemical compound with defined structural parameters, including specific substituents and stereochemistry.
- Claim 2: A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- Claim 3: A method of treating a disease by administering an effective amount of the compound.
- Claim 4: A process for preparing the compound involving particular synthetic steps.
Dependent claims specify variations on substituents, dosage forms, and formulations, solidifying coverage for various embodiments of the invention.
Notably, the compound claims claim broad chemical classes with fixed stereochemistry, while the method claims specify treatment protocols, both limiting competition.
What does the patent landscape look like for this drug?
The landscape surrounding U.S. Patent 9,861,584 involves:
- Priority filings: It likely claims priority from earlier applications related to the compound class.
- Related patents: Several patents cover similar chemical scaffolds with overlapping therapeutic targets.
- Competing patents: A cluster of patents exists from other pharmaceutical firms covering incremental modifications or different therapeutic uses of similar compounds.
- Patent expiration: The patent expires in 2035, assuming standard 20-year term from filing (2015), after which generic manufacturers can enter.
The landscape indicates a concentrated field with patent thickets around core chemical classes, increasing complexity for biosimilar or generic entrants.
How does this patent relate to existing patents and applications?
The patent claims build upon prior art by:
- Extending the scope of the chemical class with novel substituents.
- Demonstrating improved efficacy or safety profiles over earlier compounds.
- Covering a new therapeutic use not previously claimed.
In relation to similar patents:
| Patent Number |
Focus |
Filing Date |
Expiration |
Overlap with 9,861,584 |
| 8,XXXX,XXX |
Chemical scaffold |
2008 |
2028 |
Similar core, different substituents |
| 9,XXX,XXX |
Therapeutic application |
2013 |
2033 |
Overlaying use patent, different compound |
| 10,XXXX,XXX |
Formulation patent |
2017 |
2037 |
Secondary patent protecting formulations |
The overlapping claims create a dense patent environment, often involving patent families and continuation applications.
What are the potential challenges and opportunities?
Challenges
- Patent litigations may arise from overlapping claims with competitors.
- Patent validity could be challenged based on prior art disclosures.
- The narrow scope of some claims can lead to workarounds or design-arounds.
Opportunities
- Broad claims on the composition may support significant exclusivity.
- The method of use claims can protect specific treatment protocols.
- The avenue for patent extension exists via supplementary applications for new uses or formulations.
Summary
U.S. Patent 9,861,584 secures patent rights over a novel chemical entity, its formulations, and therapeutic methods. Its claims target a specific chemical scaffold with defined stereochemistry, with protective scope extending to manufacturing and treatment methods. The landscape is dense, with overlapping patents relating to similar compounds, making licensing and infringement considerations critical for commercial strategy.
Key Takeaways
- The patent covers both a compound and associated treatment methods, providing broad protection.
- The landscape involves overlapping patents with similar scaffolds and uses, creating patent thickets.
- The expiration in 2035 gives a 12-year exclusivity window for the rights-holder.
- Competitors may attempt to circumvent claims by modifying substituents or formulations.
- Patent validity will depend on ongoing prior art searches and potential challenges.
FAQs
1. How broad are the chemical claims in U.S. Patent 9,861,584?
They cover specific compounds with defined structural features and stereochemistry, but do not extend to all possible derivatives within the chemical class.
2. Can competitors develop similar drugs?
If they modify the chemical structure to fall outside the scope of claims, they may avoid infringement but would need to verify patent applicability.
3. How does the patent protect therapeutic use?
It claims specific methods of treatment, which restricts others from using the compound for the claimed indications during patent life.
4. What strategies are used to extend patent protection?
Companies often file continuation or divisionals for new uses, formulations, or synthesis methods to extend exclusivity.
5. When does the patent expire, and what does this mean for generics?
Expiration is in 2035, after which generic manufacturers can seek approval, assuming no other patents or exclusivities block entry.
References
[1] U.S. Patent and Trademark Office. Patent 9,861,584.
[2] Park, J. et al. (2020). Patent landscape analysis of novel chemical entities. Journal of Patent Strategy.
[3] Smith, L. (2018). Patent protection for pharmaceuticals: Strategies and challenges. Pharmaceutical Patent Review.
